INSIGHTS ON DRUG DEVELOPMENT

• New Approaches To Tailored Release Profiles

  Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

• Bioanalytical Quantification Of A Biotherapeutic Peptide

  Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

• Surface Plasmon Resonance for Biomolecular Interaction Analysis

  Explore how uncovering molecular interactions can drive breakthroughs in disease understanding, drug discovery, and therapeutic innovation.

• Thunderstruck By Antibody-Drug Conjugates

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• 5 Key Considerations For Companies Outsourcing Process Development

  6/9/2025

  Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

• Flow Chemistry Experiments Of Highly Hazardous Butyl Lithium Reactions

  5/22/2025

  By adopting flow chemistry for a production platform that reduces utility costs and solvent consumption, researchers can overcome the risks and challenges of Butyl Lithium chemistry.

• Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering

  7/31/2025

  Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.

• Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines

  3/24/2025

  Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

• High-Throughput IgG Quantification Assay For Cell Line Development

  4/4/2025

  Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.